The United Kingdom's market has recently faced challenges, with the FTSE 100 index experiencing declines due to weak trade data from China and a sluggish recovery in global demand. In this environment, identifying high-growth tech stocks requires focusing on companies that demonstrate resilience and innovation, capitalizing on technological advancements to drive growth despite broader economic headwinds.
Top 10 High Growth Tech Companies In The United Kingdom
| Name | Revenue Growth | Earnings Growth | Growth Rating |
|---|---|---|---|
| Audioboom Group | 8.84% | 59.33% | ★★★★★☆ |
| YouGov | 4.12% | 64.42% | ★★★★★☆ |
| Redcentric | 5.32% | 67.90% | ★★★★★☆ |
| Oxford Biomedica | 16.52% | 82.05% | ★★★★★☆ |
| Windar Photonics | 37.17% | 46.73% | ★★★★★☆ |
| Quantum Base Holdings | 132.77% | 92.87% | ★★★★★☆ |
| Trustpilot Group | 15.02% | 40.20% | ★★★★★☆ |
| Faron Pharmaceuticals Oy | 55.41% | 56.79% | ★★★★★☆ |
| Vinanz | 113.60% | 125.86% | ★★★★★☆ |
| Cordel Group | 33.50% | 148.58% | ★★★★★☆ |
Click here to see the full list of 40 stocks from our UK High Growth Tech and AI Stocks screener.
Below we spotlight a couple of our favorites from our exclusive screener.
Craneware (AIM:CRW)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Craneware plc, along with its subsidiaries, focuses on developing, licensing, and supporting computer software tailored for the healthcare industry in the United States and has a market cap of £773.92 million.
Operations: Craneware generates revenue primarily from its healthcare software segment, which brought in $198.10 million. The company operates within the U.S. healthcare sector, focusing on software solutions that support industry-specific needs.
Craneware's recent performance underscores its potential in the high-growth tech sector within the UK, with a notable 58.9% earnings growth over the past year outpacing the Healthcare Services industry's 7.4%. This growth trajectory is supported by an impressive increase in sales from $91.21 million to $100.05 million and a leap in net income from $4.06 million to $7.24 million, as reported for the half-year ending December 2024. The company also demonstrated confidence in its financial health through an increased interim dividend of 13.5 pence per share, up from last year’s 13 pence, reflecting a robust fiscal strategy and shareholder value orientation amidst dynamic market conditions.
- Get an in-depth perspective on Craneware's performance by reading our health report here.
Explore historical data to track Craneware's performance over time in our Past section.
IDOX (AIM:IDOX)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: IDOX plc, with a market cap of £260.39 million, offers software and services for managing local government and other organizations across the UK, US, Europe, and internationally.
Operations: IDOX plc generates revenue primarily from three segments: Land Property & Public Protection (£55.26 million), Communities (£17.44 million), and Assets (£14.89 million).
IDOX, a player in the UK's tech sector, is poised for robust growth with its earnings expected to surge by 24.1% annually over the next three years. This growth outstrips the broader UK market projection of 14% and is bolstered by a revenue increase forecast at 5.6% per year, surpassing the market average of 3.8%. The firm's commitment to innovation is evident from its R&D spending trends, which have consistently aligned with these ambitious growth targets, ensuring IDOX remains at the forefront of technological advancements within its industry segment. Moreover, recent strategic decisions highlighted at their Annual General Meeting underscore a proactive approach in governance and financial management, aiming to sustain and possibly accelerate this growth trajectory amidst dynamic market conditions.
- Navigate through the intricacies of IDOX with our comprehensive health report here.
Understand IDOX's track record by examining our Past report.
Informa (LSE:INF)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Informa plc is an international company specializing in organizing events, providing digital services, and supporting academic research across various regions including the United Kingdom, Continental Europe, the United States, and China, with a market capitalization of approximately £10.45 billion.
Operations: Informa generates revenue primarily through its Informa Markets segment (£1.72 billion), followed by Informa Connect (£631 million), Taylor & Francis (£698.20 million), and Informa Tech (£423.90 million).
Despite a challenging past year with earnings contracting by 28.9%, Informa has set ambitious targets for 2025, aiming for a revenue of £4.1 billion and underlying growth above 5%. This guidance comes amidst substantial share repurchases, totaling £1.49 billion since March 2022, reflecting confidence in its strategic direction. Additionally, the company's R&D focus aligns with industry trends toward digital and interactive media solutions at global events like the Middle East Energy Leadership Summit and Black Hat Asia Financial Services Summit. With an expected annual profit growth of 21%, surpassing the UK market average of 14%, Informa is poised to leverage its innovative offerings to capture emerging opportunities in the tech-driven media landscape.
- Take a closer look at Informa's potential here in our health report.
Evaluate Informa's historical performance by accessing our past performance report.
Turning Ideas Into Actions
- Get an in-depth perspective on all 40 UK High Growth Tech and AI Stocks by using our screener here.
- Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly.
- Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.
Contemplating Other Strategies?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Craneware might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com